- Cash Position: Cash and cash equivalents were $101.6 million as of March 31, 2025, compared to $34.6 million as of December 31, 2024, bolstered by $76.4 million in gross proceeds from the first ...

Aiming to enhance the eye care treatment, Sealdah Division of Eastern Railway has introduced Advanced OCT-A Technology at BR Singh Hospital.

Briana Rengifo A few months ago, when our staff first heard Paris Hilton was going to launch a new skin care brand, we had ...

Surrozen, Inc. ("Surrozen" or the "Company") (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate ...

Discover the connection between foot symptoms and heart health that could save your life. Learn which foot signs deserve ...

In this conversation, Aaron Lewandowski, M.D., emergency medicine physician and the emergency medicine stroke representative ...

A health board has been ordered to review its process for discharging prisoners back into custody after a man died after ...

Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

To address this, we propose a visibility-aware MVS using surface normal weighting (SnowMVSNet ... particularly in terms of occlusion robustness. To evaluate occlusion robustness, we constructed a ...

Indivior PLC today announced the publication of a study "Monthly Buprenorphine Depot Injection (SUBLOCADE) for Opioid Use Disorder During Pregnancy" in the American Journal on Addictions, evaluating ...

First quarter 2025 revenues of $3.0 billion; GAAP diluted EPS of $7.27 and non-GAAP diluted EPS(a) of $8.22First quarter 2025 Dupixent® global net sales (recorded by Sanofi) increased 19% to $3.67 bil ...